Dan Barrick / NHPR Granite Staters woke up to the news Tuesday that federal health agencies had recommended a pause on the distribution of the Johnson & Johnson vaccine after rare blood clots developed in six women who received it. Acting FDA Commissioner Janet Woodcock said ta review of the vaccine would likely take "a matter of days” and that the agencies are acting out of an abundance of caution. While the announcement called for a quick pivot, state health officials in New Hampshire say they were able to allocate Moderna vaccines in place of Johnson & Johnson. Vaccine providers were already expecting less Johnson & Johnson this week because of production challenges. Gov. Chris Sununu says he's confident that the pause will not slow down the vaccine rollout here.